209286-63-5 Usage
Uses
Not much information is provided in the materials regarding the specific applications of 2-(Bromomethyl)-4-chlorothieno[3,2-c]pyridine. However, given its classification as an organobromide and organochloride, it is likely that 2-(BROMOMETHYL)-4-CHLOROTHIENO[3,2-C]PYRIDINE could be used in various chemical reactions and processes that involve the formation or modification of organic molecules. Potential uses may include:
Used in Chemical Synthesis:
2-(Bromomethyl)-4-chlorothieno[3,2-c]pyridine is used as a reagent for the synthesis of other organic compounds, particularly those that require the introduction of a bromomethyl or chlorothienopyridine group. Its reactivity may be exploited in the formation of new chemical bonds or the modification of existing ones.
Used in Research and Development:
In the field of organic chemistry, 2-(Bromomethyl)-4-chlorothieno[3,2-c]pyridine may be used as a research compound to study its properties, reactivity, and potential applications. This could involve exploring its behavior in different reaction conditions or assessing its compatibility with various other chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 209286-63-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,2,8 and 6 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 209286-63:
(8*2)+(7*0)+(6*9)+(5*2)+(4*8)+(3*6)+(2*6)+(1*3)=145
145 % 10 = 5
So 209286-63-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrClNS/c9-4-5-3-6-7(12-5)1-2-11-8(6)10/h1-3H,4H2
209286-63-5Relevant academic research and scientific papers
Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
-
, (2008/06/13)
The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
